6-K 1 bak20210422_6k1.htm 6-K

SECURITIES AND EXCHANGE COMMISSION

Washington, D.C. 20549

 


 

FORM 6-K

 

REPORT OF FOREIGN PRIVATE ISSUER PURSUANT TO RULE 13A-16
OR 15D-16 OF THE SECURITIES EXCHANGE ACT OF 1934


For the month of April, 2021

(Commission File No. 1-14862 )

 


 

BRASKEM S.A.

(Exact Name as Specified in its Charter)

 

N/A

(Translation of registrant's name into English)

 


 

Rua Eteno, 1561, Polo Petroquimico de Camacari
Camacari, Bahia - CEP 42810-000 Brazil

(Address of principal executive offices)

 


 

Indicate by check mark whether the registrant files or will file annual reports under cover Form 20-F or Form 40-F.

Form 20-F ___X___       Form 40-F ______

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(1). _____

 

Indicate by check mark if the registrant is submitting the Form 6-K
in paper as permitted by Regulation S-T Rule 101(b)(7). _____

 

Indicate by check mark whether the registrant by furnishing the information contained in this Form is also thereby furnishing the information to the Commission pursuant to Rule 12g3-2(b) under the Securities Exchange Act of 1934.

Yes ______       No ___X___

If "Yes" is marked, indicate below the file number assigned to the registrant in connection with Rule 12g3-2(b): 82- _____.

 

 
 

 

BRASKEM S.A

C.N.P.J. No. 42.150.391/0001-70

NIRE 29300006939

PUBLICLY HELD COMPANY

 

DETAILED FINAL VOTING MAP

ANNUAL AND EXTRAORDINARY GENERAL MEETING

HELD ON APRIL 13, 2021

 

São Paulo, April 22, 2021 – Braskem S.A. (B3: BRKM3, BRKM5 and BRKM6; NYSE: BAK; LATIBEX: XBRK) (“Company”), in compliance with CVM Instruction No. 481/09, as amended, hereby disclose to its shareholders and the market the detailed final voting map which consolidates the voting instructions of both shareholders which voted through remote voting (boletim de voto a distância) and those present, as computed at the Annual and Extraordinary General Meeting of the Company held on April 13, 2021, including the first five digits of the shareholders’ individual or corporate taxpayer identification number (CPF or CNPJ, respectively), their vote on each item, and information about their shareholding position, as EXHIBIT I.

Further information can be obtained from Braskem’s Investor Relations Department by phone: +55 (11) 3576-9531 or by e-mail: braskem-ri@braskem.com.br

 

 

 

 
 

BRASKEM S.A

C.N.P.J. No. 42.150.391/0001-70

NIRE 29300006939

PUBLICLY HELD COMPANY

EXHIBIT I

DETAILED FINAL VOTING MAP

ANNUAL AND EXTRAORDINARY GENERAL MEETING

HELD ON APRIL 13, 2021

 

Resolutions
Annual General Meeting
1 Examine, discuss and vote on Company’s Financial Statement, containing the Notes to Financial Statements, along with the Report and Opinion of the Independent Auditors and the Opinion of the Fiscal Council, for the fiscal year ended December 31, 2020
2 Examine, discuss and vote the Management Proposal and respective Management Account for the fiscal year ended December 31, 2020
3 Resolve on the management proposal for allocation of the results in the fiscal year ended December 31, 2020
4 Do you wish to request a separate election by minority shareholders holding common shares of a member of the Fiscal Council, pursuant to article 161, paragraph 4, "a", of the Corporate Law?1
5 Do you like to request a separate election by minority shareholders who hold preferred shares of a member of the Fiscal Council, pursuant to article 161, paragraph 4, "a", of the Corporate Law?
6 Election of candidates for the Fiscal Council by the separate vote referred to in article 161, paragraph 4, item “a” of the Corporate Law) - HELOÍSA BELOTTI BEDICKS (EFFECTIVE) / REGINALDO FERREIRA ALEXANDRE (ALTERNATE)
7 Election of the fiscal board (group of candidates)
8 In case one of the candidates that compose the plate no longer integrates it to accommodate separate election that articles 161, paragraph 4, and 240 of the Brazilian Corporate Law deals with, can the votes corresponding to your shares continue to be conferred on the chosen plate?2
9

To resolve on the annual and global compensation of the administrators and members of the Company’s Fiscal Council pertaining to the fiscal year to be ended on December 31, 2021, in the total amount of R $ 72,478,883.96, referring to the annual and global remuneration of the Administrators, and the amount of R $ 1,020,637.80 referring to the remuneration of the members of the Fiscal Council

 

 

 

 


1 Such item of the resolution did not occur, reason why only the votes received by means of the Remote Voting Form were counted.

2 Such item of the resolution did not occur, reason why only the votes received by means of the Remote Voting Form were counted.

 
 

 

Extraordinary General Meeting
1 To resolve on the replacement of an alternate member of the Company’s Board of Directors, appointed by the shareholders Novonor S.A. - Under judicial reorganization (formerly known as Odebrecht S.A.) and OSP Investimentos S.A. - Under judicial reorganization (“Novonor”) to complement a term of office, until the Annual General Meeting that will resolve on the financial statements for the fiscal year to end on December 31, 2021 - LAURA MANIERO GADELHO (ALTERNATE)
2 To resolve upon the amendment and restatement of the Company’s Bylaws, according to the changes contained in the Management Proposal, to implement adjustments to matters under the authority of the Board of Directors

 

 
 

 

 

Resolution Code CNPJ/CPF
(first 5 digits)
Resolution Vote Number of Shares
(ON)(¹) (PN)(²)
Annual General Meeting
1 76423 APPROVAL                      6  -
54579 APPROVAL         4,345,162  -
59640 APPROVAL              27,647  -
33499 APPROVAL               3,747  -
89351 APPROVAL         3,353,500  -
51447 APPROVAL                      1  -
22606 APPROVAL      226,334,622  -
33000 APPROVAL      212,426,952  -
34477 APPROVAL               1,100  -
2 76423 APPROVAL                      6  -
54579 APPROVAL         4,345,162  -
59640 APPROVAL              27,647  -
33499 APPROVAL               3,747  -
89351 APPROVAL         3,353,500  -
51447 APPROVAL                      1  -
22606 APPROVAL      226,334,622  -
33000 APPROVAL      212,426,952  -
34477 APPROVAL               1,100  -
 
 

 

3 76423 APPROVAL                      6  -
54579 APPROVAL         4,345,162  -
59640 APPROVAL              27,647  -
33499 APPROVAL               3,747  -
89351 APPROVAL         3,353,500  -
51447 APPROVAL                      1  -
22606 APPROVAL      226,334,622  -
33000 APPROVAL      212,426,952  -
34477 APPROVAL               1,100  -
4 54579 ABSTENTION         4,345,162  -
 
 

 

 

 

 

5 59640 APPROVAL  -              58,346
33499 APPROVAL  -               7,911
89351 APPROVAL  -       29,152,669
32760 APPROVAL  -            273,500
40147 APPROVAL  -            135,254
21233 APPROVAL  -              17,900
55237 APPROVAL  -         4,693,844
55237 REJECTION  -            141,394
55237 ABSTENTION  -            219,044
54797 APPROVAL  -            600,487
58387 APPROVAL  -              12,584
58392 APPROVAL  -              11,900
58394 APPROVAL  -            187,155
58396 APPROVAL  -       15,555,094
58400 APPROVAL  -              39,300
58400 APPROVAL  -              88,139
58702 APPROVAL  -            261,100
59868 APPROVAL  -              56,910
59878 APPROVAL  -              43,000
62390 APPROVAL  -               8,600
71408 APPROVAL  -            243,029
71409 APPROVAL  -            125,400
71409 APPROVAL  -               2,524
71409 APPROVAL  -               1,700
72372 APPROVAL  -            102,400
72473 APPROVAL  -              54,600
74479 APPROVAL  -              18,300
74963 APPROVAL  -               5,260
75069 APPROVAL  -            878,400
75166 APPROVAL  -              25,925
76224 APPROVAL  -              31,200
82756 APPROVAL  -               9,803
90296 APPROVAL  -            110,000
90483 APPROVAL  -                  500
90633 APPROVAL  -            281,409
94700 APPROVAL  -               7,700
95596 APPROVAL  -              64,180
10205 APPROVAL  -                  420
10349 APPROVAL  -              50,900
10378 APPROVAL  -              86,880
10378 APPROVAL  -              29,729
10532 APPROVAL  -              77,089
10762 APPROVAL  -               3,100
10916 APPROVAL  -            596,201
11100 APPROVAL  -            227,271
11311 APPROVAL  -            100,451
11324 APPROVAL  -               9,500
11435 APPROVAL  -            120,207
12094 APPROVAL  -              46,200
12120 APPROVAL  -              26,100
13665 APPROVAL  -              80,900
14494 APPROVAL  -               6,709
14541 APPROVAL  -              95,000
14581 APPROVAL  -              29,587
14693 APPROVAL  -              26,800
16878 APPROVAL  -               5,300
17718 APPROVAL  -            263,300
17858 APPROVAL  -              19,500
18608 APPROVAL  -            211,000
18682 APPROVAL  -              14,900
18682 APPROVAL  -               5,800
18830 APPROVAL  -              11,500
19244 APPROVAL  -               1,000
19609 APPROVAL  -              31,681
20065 APPROVAL  -              88,798
20196 APPROVAL  -              51,300
20849 APPROVAL  -                  600
21141 APPROVAL  -              21,999
21290 APPROVAL  -            111,400
22403 APPROVAL  -         1,236,400
22420 APPROVAL  -            464,540
23020 APPROVAL  -              23,466
23572 APPROVAL  -              14,100
23771 APPROVAL  -            145,568
24528 APPROVAL  -              59,900
24528 APPROVAL  -              67,600
26160 APPROVAL  -               2,300
26311 APPROVAL  -               2,000
26772 APPROVAL  -              32,400
27778 APPROVAL  -              31,700
28072 APPROVAL  -                  200
28360 APPROVAL  -                  299
28394 APPROVAL  -               9,000
28990 APPROVAL  -              52,000
29322 APPROVAL  -         1,711,355
29522 APPROVAL  -              13,800
30347 APPROVAL  -            405,200
30918 APPROVAL  -            126,207
31064 APPROVAL  -               5,207
31240 APPROVAL  -              13,700
31577 APPROVAL  -               1,400
32106 APPROVAL  -               2,750
32241 APPROVAL  -            567,340
32329 APPROVAL  -              81.336
33580 APPROVAL  -              22.400
34825 APPROVAL  -                  886
35612 APPROVAL  -               1.000
35693 APPROVAL  -            779.300
35859 APPROVAL  -               8.100
36352 APPROVAL  -                    -   
37113 APPROVAL  -               2.800
38251 ABSTENTION  -              70.000
40922 APPROVAL  -              19.200
41222 APPROVAL  -               7.500
97539 APPROVAL  -              38.271
97539 APPROVAL  -              40.400
97539 APPROVAL  -              25.870
97539 APPROVAL  -            699.018
97539 APPROVAL  -              54.177
97540 APPROVAL  -            161.491
97540 APPROVAL  -              37.928
97540 APPROVAL  -            853.745
97540 APPROVAL  -         2.009.383
 
 

 

 

 

 

6 59640 APPROVAL  -              58.346
33499 APPROVAL  -               7.911
89351 APPROVAL  -       29.152.669
32760 APPROVAL  -            273.500
40147 APPROVAL  -            135.254
21233 APPROVAL  -              17,900
55237 APPROVAL  -         4,663,742
55237 REJECTION  -            153,368
55237 ABSTENTION  -            237,172
54797 APPROVAL  -            600,487
58387 APPROVAL  -              12,584
58392 APPROVAL  -              11,900
58394 APPROVAL  -            187,155
58396 APPROVAL  -       15,555,094
58400 APPROVAL  -              39,300
58400 APPROVAL  -              88,139
58702 APPROVAL  -            261,100
59868 APPROVAL  -              56,910
59878 APPROVAL  -              43,000
62390 APPROVAL  -               8,600
71408 APPROVAL  -            243,029
71409 APPROVAL  -            125,400
71409 APPROVAL  -               2,524
71409 APPROVAL  -               1,700
72372 APPROVAL  -            102,400
72473 APPROVAL  -              54,600
74479 APPROVAL  -              18,300
74963 APPROVAL  -               5,260
75069 APPROVAL  -            878,400
75166 APPROVAL  -              25,925
76224 APPROVAL  -              31,200
82756 APPROVAL  -               9,803
90296 APPROVAL  -            110,000
90483 APPROVAL  -                  500
90633 APPROVAL  -            281,409
94700 APPROVAL  -               7,700
95596 APPROVAL  -              64,180
10205 APPROVAL  -                  420
10349 APPROVAL  -              50,900
10378 APPROVAL  -              86,880
10378 APPROVAL  -              29,729
10532 APPROVAL  -              77,089
10762 APPROVAL  -               3,100
10916 APPROVAL  -            596,201
11100 APPROVAL  -            227,271
11311 APPROVAL  -            100,451
11324 APPROVAL  -               9,500
11435 APPROVAL  -            120,207
12094 APPROVAL  -              46,200
12120 APPROVAL  -              26,100
13665 APPROVAL  -              80,900
14494 APPROVAL  -               6,709
14541 APPROVAL  -              95,000
14693 APPROVAL  -              26,800
17718 APPROVAL  -            263,300
18608 APPROVAL  -            211,000
18682 APPROVAL  -              14,900
18682 APPROVAL  -               5,800
18830 APPROVAL  -              11,500
19244 APPROVAL  -               1,000
20849 APPROVAL  -                  600
21141 APPROVAL  -              21,999
21290 APPROVAL  -            111,400
22403 APPROVAL  -         1,236,400
22420 APPROVAL  -            464,540
23020 APPROVAL  -              23,466
23572 APPROVAL  -              14,100
23771 APPROVAL  -            145,568
24528 APPROVAL  -              59,900
24528 APPROVAL  -              67,600
26160 APPROVAL  -               2,300
26311 APPROVAL  -               2,000
26772 APPROVAL  -              32,400
27778 APPROVAL  -              31,700
28072 APPROVAL  -                  200
28360 APPROVAL  -                  299
28394 APPROVAL  -               9,000
28990 APPROVAL  -              52,000
29522 APPROVAL  -              13,800
30347 APPROVAL  -            405,200
31064 APPROVAL  -               5,207
31577 APPROVAL  -               1,400
32241 APPROVAL  -            567,340
33580 APPROVAL  -              22,400
34825 APPROVAL  -                  886
35612 APPROVAL  -               1,000
36352 APPROVAL  -                    -   
37113 APPROVAL  -               2,800
40922 APPROVAL  -              19,200
41222 APPROVAL  -               7,500
7 76423 REJECTION                      6  -
54579 APPROVAL         4,345,162  -
59640 APPROVAL              27,647  -
33499 APPROVAL               3,747  -
89351 ABSTENTION         3,353,500  -
51447 APPROVAL                      1  -
22606 APPROVAL      226,334,622  -
33000 APPROVAL      212,426,952  -
34477 APPROVAL               1,100  -
8 54579 ABSTENTION         4,345,162  -
 
 

 

9 76423 REJECTION                      6  -
54579 APPROVAL         4,345,162  -
59640 APPROVAL              27,647  -
33499 APPROVAL               3,747  -
89351 APPROVAL         3,353,500  -
51447 APPROVAL                      1  -
22606 APPROVAL      226,334,622  -
33000 APPROVAL      212,426,952  -
34477 APPROVAL               1,100  -
Extraordinary General Meeting
1 76423 ABSTENTION                      6  -
54579 APPROVAL         4,345,162  -
59640 ABSTENTION              27,647  -
33499 ABSTENTION               3,747  -
89351 ABSTENTION         3,353,500  -
51447 APPROVAL                      1  -
22606 APPROVAL      226,334,622  -
33000 APPROVAL      212,426,952  -
34477 APPROVAL               1,100  -
2 76423 APPROVAL                      6  -
54579 APPROVAL         4,345,162  -
59640 APPROVAL              27,647  -
33499 APPROVAL               3,747  -
89351 ABSTENTION         3,353,500  -
51447 APPROVAL                      1  -
22606 APPROVAL      226,334,622  -
33000 APPROVAL      212,426,952  -
34477 APPROVAL               1,100  -
 
 

 

(1) ON shares are common shares issued by the Company. It does not take into consideration Treasury Stock.

(2) PN Shares are preferred shares of class A and B issued by the Company, which have the right to vote only and exclusively for separate election of the Fiscal Council, under the terms of article 161, paragraph 4, item "a", of Corporation Law. It does not take into consideration Treasury Stock.

 
 

SIGNATURES

        Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned, thereunto duly authorized.

Date: April 22, 2021

  BRASKEM S.A.
       
       
  By:      /s/     Pedro van Langendonck Teixeira de Freitas
     
    Name: Pedro van Langendonck Teixeira de Freitas
    Title: Chief Financial Officer

 

DISCLAIMER ON FORWARD-LOOKING STATEMENTS

 

This report on Form 6-K may contain forward-looking statements within the meaning of the Private Securities Litigation Reform Act of 1995. These statements are statements that are not historical facts, and are based on our management’s current view and estimates of future economic and other circumstances, industry conditions, company performance and financial results, including any potential or projected impact of the geological event in Alagoas and related legal proceedings and of COVID-19 on our business, financial condition and operating results. The words “anticipates,” “believes,” “estimates,” “expects,” “plans” and similar expressions, as they relate to the company, are intended to identify forward-looking statements. Statements regarding the potential outcome of legal and administrative proceedings, the implementation of principal operating and financing strategies and capital expenditure plans, the direction of future operations and the factors or trends affecting our financial condition, liquidity or results of operations are examples of forward-looking statements. Such statements reflect the current views of our management and are subject to a number of risks and uncertainties, many of which are outside of the our control. There is no guarantee that the expected events, trends or results will actually occur. The statements are based on many assumptions and factors, including general economic and market conditions, industry conditions, and operating factors. Any changes in such assumptions or factors, including the projected impact of the geological event in Alagoas and related legal proceedings and the unprecedented impact of COVID-19 pandemic on our business, employees, service providers, stockholders, investors and other stakeholders, could cause actual results to differ materially from current expectations. Please refer to our annual report on Form 20-F for the year ended December 31, 2019 filed with the SEC, as well as any subsequent filings made by us pursuant to the Exchange Act, each of which is available on the SEC’s website (www.sec.gov), for a full discussion of the risks and other factors that may impact any forward-looking statements in this presentation.